Staking an Advantage in an AIA World: Practical Patent Tips for Biotechnology Companies
DOI:
https://doi.org/10.5912/jcb652Keywords:
AIA, patent, prior art, IP liaisonAbstract
With passage of the Leahy-Smith America Invents Act (AIA), new rules and procedures related to the application of prior art now apply to patenting under a “first-inventor-to-file†system. This article summarizes certain key prior art provisions that biotechnology companies should be aware of and details practical steps that can be implemented to help stake a competitive advantage under the new law including the use of patent liaisons, early provisional and patent application filings, and in certain circumstances, defensive publication of patentable subject matter.
References
Title 35 of the United States Code (U.S.C.), Section (§) 102 (enacted 2012) available online at http://www.law.cornell.edu/uscode/text/35/102?qt-us_code_tabs=0 (accessed 26 February 2014).
U.S.C. § 122
U.S.C. § 305
AIA Frequently Asked Questions (2013). USPTO, 30 October. http://www.uspto.gov/aia_implementation/faqs_first_inventor.jsp, accessed 26 February 2014.
American Intellectual Property Law Association (2012) Summary of the America Invents Act. http://www.aipla.org/advocacy/congress/aia/Pages/summary.aspx, accessed 26 February 2014
Fox, J. (2011) America Invents Act receives cautious welcome. Nature Biotechnology. 29: 953–954
Intellectual Property Owners Association (2011) Comparison of Selected Sections of Pre-AIA and AIA U.S. Patent Law https://www.ipo.org/ wp-content/ uploads/ 2013/ 03 /Patent_ Reform_ Chart_ Comparison_ of_ AIA_ and_ Pre-AIA_ Laws_FINAL.pdf, accessed 26 February 2014.
Knight, J. (2013) Patent strategy for researchers and research managers, 3rd ed. Chichester, West Sussex, U.K.: John Wiley at ch. 3
Leahy-Smith America Invents Act, H.R. 1249 (112th Congress, First Session), enacted (President Obama) 16 September 2011, available online at http://www.gpo.gov/ fdsys/ pkg/ PLAW-112publ29/content-detail.html (accessed 24 February 2014).
Lu, D., Kowalkski, T., Uthaman, S. (2012) Are laboratory notebooks necessary in a first inventor to file world? Journal of Commercial Biotechnology. 18(3): 67–68.
Luke Johnston (2011) The biggest groups are ill with inefficiency. Financial Times. 5 April. http://www.ft.com/intl/cms/s/0/863409bc-5fca-11e0-a718-00144feab49a.html#axzz2uMzj3yLQ, accessed 25 February 2014
Rao N. (2013) Opinion: AIA Does Not Discriminate. The Scientist. 21 August. http://www.the-scientist.com/?articles.view/articleNo/37133/title/Opinion--AIA-Does-Not-Discriminate/, accessed 26 February 2014
Rondeaue, G. (2011) “America Invents Act†patent law overhaul: the benefits and the drawbacks. Lexology. 17 November. http://www.lexology.com /library/detail.aspx?g=5f772592-7ac2-41bc-becb-d3ff5c8ed192, accessed 26 February 2014.
Rzucidlo, G. and Miller, S. (2008) Aggressive Intellectual Property Strategies. In Friedman, Y. (ed.) Best Practices in Biotechnology Business Development, ed. Yali Friedman, US: Logos Press, pp. 61–80
Uthaman (2012) Post-grant review: The good, the bad and the ugly for biotechnology companies.
Uthaman, S., Lu, D., and Kowalski, T. (2012) Post-grant review: The good, the bad and the ugly for biotechnology companies. Journal of Commercial Biotechnology 18(1): 97–99
